ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 146 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $282,000 | -37.2% | 20,470 | -27.6% | 0.00% | – |
| Q1 2022 | $449,000 | -46.6% | 28,270 | -25.9% | 0.00% | -100.0% |
| Q4 2021 | $841,000 | -45.8% | 38,132 | -26.5% | 0.00% | 0.0% |
| Q3 2021 | $1,551,000 | -32.2% | 51,907 | +0.5% | 0.00% | -50.0% |
| Q2 2021 | $2,286,000 | -52.2% | 51,632 | -52.1% | 0.00% | -60.0% |
| Q1 2021 | $4,784,000 | +3.4% | 107,826 | +27.8% | 0.01% | 0.0% |
| Q4 2020 | $4,627,000 | +139.2% | 84,377 | -0.3% | 0.01% | +150.0% |
| Q3 2020 | $1,934,000 | -0.8% | 84,636 | -9.1% | 0.00% | 0.0% |
| Q2 2020 | $1,949,000 | +121.0% | 93,123 | +47.2% | 0.00% | +100.0% |
| Q1 2020 | $882,000 | -25.1% | 63,250 | +22.1% | 0.00% | 0.0% |
| Q4 2019 | $1,178,000 | +13.2% | 51,788 | -42.0% | 0.00% | 0.0% |
| Q3 2019 | $1,041,000 | – | 89,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |